Northwestern University Feinberg School of Medicine
Skip to main content

News and Breakthroughs

Find the latest news and discoveries, as well highlights from Lurie Cancer Center’s programs and events through the links below. To learn more about our accomplishments and the people who make them possible, visit the article archive for older news and read our 2020 Year in Review.

Visit our gallery to view a wide range of photos and videos for oncology professionals, cancer patients and families, cancer survivors, caregivers and community members.

  • 05.27.2022

    Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will present and discuss leading-edge research in cancer care at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7 at McCormick Place in Chicago and Online.

  • 05.25.2022

    The Cancer Immunology and Immunotherapy Initiative at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University is bringing together Feinberg investigators who study immunotherapy to increase collaboration and accelerate high-impact immunotherapy research.

  • 05.25.2022

    Investigators have discovered the mechanisms underlying a T-cell receptor’s immunosuppressive function, findings that may improve the development of precision therapeutics for chronic disease, including cancer.

  • 05.23.2022

    William Gradishar, MD, chief of Hematology and Oncology in the Department of Medicine and deputy director of the clinical network of the Lurie Cancer Center, has received the 2022 Rodger Winn Award from the National Comprehensive Cancer Network.

  • 05.20.2022

    A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer.

  • 05.19.2022

    Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.

  • 05.16.2022

    A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.

  • 05.13.2022

    Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.

  • 05.13.2022

    On Friday, May 13, 2022, the Translational Research in Solid Tumors (TRIST) Program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University hosted the TRIST Symposium on the Chicago campus of Northwestern University. The focus of the program is "Drug Development from Bench to Bedside".

  • 05.11.2022

    For cancer survivors like Kanesha Broadwater, BSN, RN, OCN, it’s important to continue receiving necessary cancer care—even during a pandemic.

  • 05.10.2022

    A transcription factor associated with androgen receptor activity in prostate cancer has a newly discovered role in controlling lipid biosynthesis.

  • 05.06.2022

    Northwestern Medicine scientists identified critical regulatory processes that govern differentiation in embryonic stem cells.

  • 05.05.2022

    Lurie Cancer Center has named Marquita Lewis-Thames, PhD; June McKoy, MD, MPH, JD, MBA; Jonathan Moreira, MD; and Adam B. Murphy, MD, MBA, MSCI, to new leadership roles within the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 

  • 04.26.2022

    The protein FOXK2 promotes survival of cancer stem cells in ovarian cancer, according to a Northwestern Medicine study.

  • 04.21.2022

    After he was diagnosed with kidney cancer at the age of 34, Jon Resnick and his wife, Amy, signed up for their first Cancer Survivors’ Celebration Walk & 5K. Together with daughters Lindsey and Jordyn, they haven’t missed a year supporting Jon and celebrating as a family since 2003! Lindsey and Jordyn, who first joined our event in strollers, now travel from wherever they are. “It’s a priority,” says Amy. “We have to be here every year.”

  • 04.19.2022

    Investigators have discovered a novel signaling pathway in interferons that suppresses their anti-tumor response in patients with a particular type of blood cancer.

  • 04.18.2022

    To Judith Mayzel, philanthropy at Northwestern University Feinberg School of Medicine is all about community: donors, scientists, physicians, and trainees all working together to make the world a better place.

  • 04.14.2022

    A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within different parts of brain tumor and brain metastasis microenvironments.

  • 03.29.2022

    Investigators discovered that decreased expression of the G alpha 13 protein in mice and human pancreatic tumors promotes tumor growth, according to recent findings.

  • 03.28.2022

    After two years of celebrating virtually, Lurie Cancer Center and Northwestern Medicine will welcome cancer survivors and supporters back to Grant Park on Sunday, June 5, 2022 for the 29th Annual Cancer Survivors’ Celebration Walk and 5K!

  • 03.22.2022

    Nine members of the Lurie Cancer Center are among the “world’s most influential scientific minds,” according to the Highly Cited Researchers (HCR) list released by Clarivate Analytics, part of the Web of Science Group. The list recognizes “true pioneers in their fields over the last decade,” demonstrated by the publication of multiple papers that rank in the top 1% of scholarly publication cited by their peers.

  • 03.21.2022

    Daniel Brat, MD, PhD, has been heavily involved in the process of moving molecular genetic biomarkers for glioma from the bench to the beside.

  • 03.16.2022

    A well-established cancer cell transcription factor and its newly identified co-factor work together to drive cancer cell proliferation, according to a Northwestern Medicine study published in Science Advances.

  • 03.16.2022

    Martin S. Tallman, MD, will join the Lurie Cancer Center as Director of Faculty Mentorship and Career Development, effective June 1, 2022. An internationally renowned clinician and scientist, he will focus on the management and development of new treatments for patients with both acute and chronic leukemias.

  • 03.10.2022

    Last fall a string of fortuitous connections led to a special gift from one of the medical school’s legendary donors to help equalize healthcare for Black women in Chicago.

  • 03.09.2022

    A vital partner to Northwestern, the Lynn Sage Breast Cancer Foundation makes it possible for our scientists and clinicians to pioneer research and provide cutting-edge care to patients going through a very difficult experience. We are so grateful for the foundation’s insightful and impactful fundraising and generosity.

  • 03.08.2022

    Black women with early hormone receptor-positive breast cancer experienced shorter relapse-free intervals and overall survival compared with white women, according to findings published in JAMA Oncology.

  • 03.02.2022

    On Thursday, March 3, Atieh Hajirahimkhan, PhD, an American Cancer Society postdoctoral fellow at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, will meet with members of Congress as part of the seventh annual American Association for Cancer Research (AACR) Early-career Hill Day.

  • 02.25.2022

    Patients receiving radiotherapy to treat high-risk prostate cancer benefit from androgen deprivation therapy, and length of treatment may be dependent on radiation deliver, according to a recent study.

See more news in the article archive.